• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

10 Black Americans Who Have Led COVID-19 Response
By The Editorial Team, IntraHealth InternationalFebruary 22, 2022Meet 10 Black American leaders who are shaping local and national COVID-19 response. These scientists, researchers, policymakers, teachers, and more have seen first-hand how the pandemic exacerbates racial disparities in health. In the US, Black Americans have died from COVID-19 at1.4 times the rate of white people.Today we’re highlighting these leaders as they work to protect their communities and inform our global response to the pandemic.Christopher BarnesAssistant professor, Department of Biology at Stanford UniversityWhen COVID-19 began, Bar...
Source: IntraHealth International - February 17, 2022 Category: International Medicine & Public Health Authors: kseaton Tags: COVID-19 Health Workers Source Type: news

Top Global Health Moments of 2020
By The Editorial Team, IntraHealth International Community Health Nurse Olivia Yeboah thoroughly washes her hands at the Akropong Clinic in Ghana. Photo by Emmanuel Attramah, PMI Impact Malaria/US President ' s Malaria Initiative.December 17, 2020If we wanted to, we could list a COVID-19 moment for every month of 2020.  We all know that the onset of the coronavirus pandemic—first in China and then worldwide—overwhelmed news coverage this year. And with good reason. It’s the first large-scale global pandemic in 100 years. At the time this article was pu...
Source: IntraHealth International - December 17, 2020 Category: International Medicine & Public Health Authors: kseaton Tags: HIV & AIDS COVID-19 Nutrition Policy Advocacy Health Workforce Systems Nursing Midwifery 2020 Health Workers Source Type: news

The Covid Pandemic: Broadening the Discourse
Thailand’s COVID-19 response an example of resilience and solidarity: a UN Resident Coordinator’s BlogBy Asoka BandarageCOLOMBO, Sri Lanka, Nov 10 2020 (IPS) SARS-CoV-2, the corona virus that causes COVID-19, has been spreading exponentially across the world over the last ten or so months. As of November 6th, according to the Center for Systems Science at Johns Hopkins University, there have been 49,195,581 cases of COVID-19, including 1,241,031 deaths. More than a third of the global population has been placed on lockdown. The global economy is experiencing the deepest global recession since World War 2 and massive n...
Source: IPS Inter Press Service - Health - November 10, 2020 Category: International Medicine & Public Health Authors: Asoka Bandarage Tags: Featured Global Headlines Health Human Rights Humanitarian Emergencies Peace TerraViva United Nations Source Type: news

Experimental COVID-19 vaccine protects upper and lower airways in nonhuman primates
(NIH/National Institute of Allergy and Infectious Diseases) Two doses of an experimental vaccine to prevent coronavirus disease 2019 (COVID-19) induced robust immune responses and rapidly controlled the coronavirus in the upper and lower airways of rhesus macaques exposed to SARS-CoV-2, report scientists from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. SARS-CoV-2 is the virus that causes COVID-19.
Source: EurekAlert! - Medicine and Health - July 28, 2020 Category: International Medicine & Public Health Source Type: news

Phase 3 clinical trial of investigational vaccine for COVID-19 begins
(NIH/National Institute of Allergy and Infectious Diseases) A Phase 3 clinical trial designed to evaluate if an investigational vaccine can prevent symptomatic coronavirus disease 2019 (COVID-19) in adults has begun. The vaccine, known as mRNA-1273, was co-developed by the Cambridge, Massachusetts-based biotechnology company Moderna, Inc., and the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. The trial is expected to enroll approximately 30,000 adult volunteers who do not have COVID-19 at U.S. clinical research sites.
Source: EurekAlert! - Medicine and Health - July 27, 2020 Category: International Medicine & Public Health Source Type: news

Covid-19 Is Not Gender-Neutral
By Andrea UlrichJune 09, 2020As people around the world continue to face the effects of COVID-19, academic institutions and government policymakers are turning to data more than ever to understand the scope of the crisis, anticipate its spread, and formulate policy decisions.One example of existing high quality, real-time data is theJohns Hopkins’ COVID-19 dashboard, which has expanded as a data resource as the crisis grows. While policymakers and experts are relying on these resources, it is crucial to understand what information is being captured and what is not, as making decisions with incomplete or faulty data h...
Source: IntraHealth International - June 8, 2020 Category: International Medicine & Public Health Authors: cbishopp Tags: COVID-19 Digital Health Source Type: news

NIAID strategic plan details COVID-19 research priorities
(NIH/National Institute of Allergy and Infectious Diseases) Urgent public health measures are needed to control the spread of the novel coronavirus (SARS-CoV-2) and the disease it causes, COVID-19. Scientific research to improve our understanding of the virus and how it causes disease, and to develop strategies to mitigate illness and death, is of paramount importance. A new strategic plan from the National Institute of Allergy and Infectious Diseases details the institute's plan for accelerating research to diagnose, prevent and treat COVID-19.
Source: EurekAlert! - Medicine and Health - April 22, 2020 Category: International Medicine & Public Health Source Type: news

Rapid COVID-19 Vaccine Development: An Example of the Prototype Pathogen Approach for Pandemic Preparedness
Source: National Institute of Allergy and Infectious Diseases [National Institutes of Health] (NIAID). Published: 4/22/2020. In this one-hour presentation, the speaker discusses the prototype pathogen approach for pandemic preparedness that has been applied to the Middle East respiratory syndrome coronavirus (MERS CoV) over the last seven years, and explains the prototype pathogen approach in the context of developing a rapid COVID-19 vaccine. (Video or Multimedia)
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - April 22, 2020 Category: International Medicine & Public Health Source Type: news

Biomedical Research Response to COVID-19: A View from NIAID (National Institute of Allergy and Infectious Diseases)
Source: National Institutes of Health (NIH). Published: 4/15/2020. This hour-long presentation details how the National Institute of Allergy and Infectious Diseases (NIAID) has tapped existing coronavirus expertise and other assets during the COVID-19 pandemic to stand up research programs spanning basic virology and immunology through to countermeasure development (diagnostics, therapeutics, and vaccines). As the outbreak has expanded, so too has the NIAID research program and the scope of the problems it seeks to solve. (Video or Multimedia)
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - April 15, 2020 Category: International Medicine & Public Health Source Type: news

TB, HIV and COVID-19: Urgent Questions as Three Epidemics Collide
This article is republished from The Conversation under a Creative Commons license. Read the original article. The post TB, HIV and COVID-19: Urgent Questions as Three Epidemics Collide appeared first on Inter Press Service.
Source: IPS Inter Press Service - Health - March 25, 2020 Category: International Medicine & Public Health Authors: External Source Tags: Africa Headlines Health Source Type: news

COVID-19 a reminder of the challenge of emerging infectious diseases
(NIH/National Institute of Allergy and Infectious Diseases) The emergence and rapid increase in cases of coronavirus disease 2019 (COVID-19), a respiratory illness caused by a novel coronavirus, pose complex challenges to the global public health, research and medical communities, write federal scientists from NIH's National Institute of Allergy and Infectious Diseases (NIAID) and from the Centers for Disease Control and Prevention (CDC). Their commentary appears in The New England Journal of Medicine.
Source: EurekAlert! - Medicine and Health - February 28, 2020 Category: International Medicine & Public Health Source Type: news

MERS antibodies produced in cattle safe, treatment well tolerated in phase 1 trial
(NIH/National Institute of Allergy and Infectious Diseases) An experimental treatment developed from cattle plasma for Middle East respiratory syndrome (MERS) coronavirus infection shows broad potential, according to a small clinical trial led by National Institutes of Health scientists and their colleagues. The treatment, SAB-301, was safe and well tolerated by healthy volunteers, with only minor reactions documented.
Source: EurekAlert! - Medicine and Health - January 9, 2018 Category: International Medicine & Public Health Source Type: news